Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim enters discovery stage collaboration with Trutino Biosciences
Pharmaceutical Business Review
Fri, 02/28/20 - 10:31 am
Boehringer Ingelheim
Trutino Biosciences
R&D
FDA Approves Eli Lilly's and Boehringer Ingelheim Pharmaceuticals' Triple-Combination Diabetes Drug Trijardy XR
Motley Fool
Tue, 01/28/20 - 12:04 pm
FDA
Eli Lilly
Boehringer Ingelheim
Trijardy XR
Jardiance
Tradjenta
metformin
diabetes
AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque Psoriasis
Motley Fool
Wed, 01/15/20 - 10:56 am
AbbVie
Boehringer Ingelheim
Skyrizi
Novartis
Cosentyx
psoriasis
Boehringer Ingelheim inks 'Singapore's largest biotech deal,' promising $1B each for a suite of anti-fibrotic IL-11 drugs
Endpoints
Thu, 01/9/20 - 09:59 am
Boehringer Ingelheim
Singapore
fibrotic disease
Boehringer cleared to manufacture BeiGene’s cancer drug for Chinese market
Pharmaforum
Fri, 01/3/20 - 09:45 am
Boehringer Ingelheim
China
BeiGene
drug manufacturing
As NASH shifts again, the focus remains on Genfit’s big readout
EP Vantage
Wed, 12/18/19 - 10:53 am
NASH
Genfit
elafibranor
Pfizer
Boehringer Ingelheim
Gilead Sciences
Poxel
Takeda
Intercept Pharma
Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint
Pharmaceutical Business Review
Mon, 12/16/19 - 10:35 am
Jardiance
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
chronic heart failure
clinical trials
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Fierce Pharma
Fri, 12/13/19 - 09:05 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
Farxiga
diabetes
AstraZeneca
heart failure
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
Fierce Pharma
Mon, 11/18/19 - 10:29 am
diabetes
AHA
heart failure
Eli Lilly
Boehringer Ingelheim
Jardiance
clinical trials
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes
Zacks.com
Thu, 11/14/19 - 10:25 am
Eli Lilly
Boehringer Ingelheim
FDA
Jardiance
type 1 diabetes
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Pharmaceutical Business Review
Wed, 11/13/19 - 10:02 am
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
Lilly and Boehringer rejig diabetes alliance as Jardiance soars
Pharmaforum
Tue, 11/5/19 - 10:21 am
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
type 2 diabetes
Which big pharma firms are best at digital?
Pharmaforum
Wed, 10/16/19 - 12:28 pm
digital pharma
Bayer
Pfizer
Boehringer Ingelheim
Boehringer's VC wing backs anti-cancer virus startup
Fierce Biotech
Tue, 10/15/19 - 10:00 am
Abalos Therapeutics
arenavirus
Boehringer Ingelheim
cancer
As developers work on cracking KRAS, Germany's Boehringer has quietly begun testing its pan-KRAS drug in humans
Endpoints
Wed, 10/2/19 - 07:42 pm
KRAS
cancer
Boehringer Ingelheim
Boehringer Ingelheim's Ofev cuts rate of decline by 57% in range of rare lung diseases
Fierce Pharma
Tue, 10/1/19 - 10:59 pm
Boehringer Ingelheim
Ofev
idiopathic pulmonary fibrosis
Boehringer Ingelheim signs retinal disease deal with Inflammasome
Pharmaceutical Business Review
Tue, 09/24/19 - 09:26 am
Boehringer Ingelheim
Inflammasome Therapeutics
retinal disease
EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod
Fierce Pharma
Tue, 09/17/19 - 11:00 am
Eli Lilly
Boehringer Ingelheim
Jardiance
kidney disease
JNJ
EASD
ICER dings Novo's new oral diabetes drug
Biopharma Dive
Wed, 09/11/19 - 11:41 pm
Novo Nordisk
diabetes
ICER
oral semaglutide
Eli Lilly
Boehringer Ingelheim
Jardiance
Ozempic
Boehringer Ingelheim’s Ofev secures FDA approval for SSc-ILD
Pharmaceutical Business Review
Mon, 09/9/19 - 10:32 am
Ofev
SSc-ILD
Boehringer Ingelheim
FDA
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »